We’re proud to be a sponsor of the Lupus Foundation of America, Inc. #WalkToEndLupusNow. This event unites communities to raise awareness and support around #lupus research, education, and programs that make a difference in the lives of the 1.5 million Americans impacted by this disease. We encourage you to join us in spreading the word and share “why you walk” in the comments below!
Nkarta, Inc.
Biotechnology Research
South San Francisco, California 11,781 followers
Harnessing the Power of Natural Killer Cells
About us
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.
- Website
-
http://www.nkartatx.com
External link for Nkarta, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 2015
- Specialties
- Cell Therapy, Immuno-Oncology, and Autoimmune Disease
Locations
-
Primary
1150 Veterans Blvd.
South San Francisco, California 94080, US
Employees at Nkarta, Inc.
Updates
-
Through our ongoing partnership with Life Science Cares Bay Area, the Nkarta team volunteered with HealthRIGHT 360 to create a dedicated children’s area at a residential treatment facility in San Francisco. Thanks to generous donations from Nkartans, the new children's area is filled with items to provide a welcoming and engaging environment for children and their parents. We are thankful for the opportunity to give back to our local community.
-
David Shook, our Chief Medical Officer and Head of Research & Development, will be a panelist at the Fierce Life Sciences Events Biotech Summit later this month. He will participate in a panel discussion about the evolution of cell therapy uses – from #oncology to #lupus and #autoimmune diseases. Learn more: https://lnkd.in/gZiJ8nHE
-
Building on our patient-first approach and platform for on-demand, off-the-shelf #NKcell therapies, we’re working to pioneer groundbreaking treatments that are broadly accessible in the outpatient setting. We’re excited by what the latest breakthroughs in cell therapy may hold for the future of #autoimmune treatment landscape and their potential to address unmet need in diseases such as systemic sclerosis.
-
The recent FDA clearance of our Investigational New Drug (IND) application in three additional #autoimmune diseases takes us one step closer to realizing our mission of bringing transformative #NKcell therapy to patients in need. We’re committed to improving the quality of life for people living with scleroderma, vasculitis and myositis.
-
We’re dedicated to building awareness of ANCA vasculitis and #autoimmune disease, while advancing the promise of #NKcell therapy to improve accessibility for people living with this disease.
-
#InternSpotlight: We are grateful for our summer interns! This incredible group took on key projects that support our mission to deliver safe and accessible cell therapies to people living with autoimmune disease and cancer. They made a significant impact, and integrated seamlessly into our team, bringing hard work and enthusiasm. Thank you, Mya Jefferies, Aaron Susantin, Raymond Ruiz, Lilian Barbosa, Chris S., Nidia Rodriguez, and Nicole C. – best of luck in everything you do!
-
Through our ongoing partnership with Life Science Cares Bay Area, we volunteered with Northern Marin Community Services and Upward Scholars to prepare 200 backpacks filled with school essentials for students in need. These backpacks will benefit students from kindergarten through college. We look forward to more opportunities to support our local community!
-
The next frontier of #NKcell therapy has the potential to uncover new treatment options for patients in need. One area of autoimmune disease we are focused on is myositis. Watch and learn more about the signs and symptoms people living with this disease experience.
-
We’re committed to redefining the autoimmune disease treatment landscape by harnessing the body’s natural killer cells – the immune system’s first responders – to deliver a cell therapy that is safer, more tolerable and more accessible to people living with serious autoimmune diseases, including systemic sclerosis. Watch and learn more: